Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
Elemento
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicaciónTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Título
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
Materia
Descripción
Rapid vaccine-induced population immunity is a key global strategy to control COVID-19. Vaccination programmes must maximise early impact, particularly with accelerated spread of new variants.
Fecha
2021-02-25
Tipo
Citación
Manisty, Charlotte, Ashley D. Otter, Thomas A. Treibel, Áine McKnight, Daniel M. Altmann, Timothy Brooks, Mahdad Noursadeghi, Rosemary J. Boyton, Amanda Semper, and James C. Moon. 2021. "Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals." The Lancet.
Accesibilidad
Free online on Lancet site.
Was this resource helpful?